Eliana Clark Intellia Therapeutics, Inc. (NTLA) insider trading activity
Eliana Clark is EVP, Chief Technical Officer of Intellia Therapeutics, Inc.. Currently has a direct ownership of 95,369 shares of NTLA, which is worth approximately $1.03 Million. The most recent transaction as insider was on Jul 01, 2025, when has been sold 1,022 shares (Common Stock) at a price of $9.82 per share, resulting in proceeds of $10,036. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
95.4K
0%
3M change
33.44%
12M change
Total Value Held
$1.03 Million
Eliana Clark Transaction History
EC
Eliana Clark
EVP, Chief Technical Officer
Cambridge, MA